Acute Kidney Injury Linked to Higher Risk of Some Forms of Dementia

Translate to Spanish or other 102 languages!

Acute kidney injury may be another dementia risk factor to be aware of. Image credit: Raymond Forbes LLC/Stocksy. Image for illustration purposes
Acute kidney injury may be another dementia risk factor to be aware of. Image credit: Raymond Forbes LLC/Stocksy. Image for illustration purposes
- Advertisement -

Researchers recently published a study about whether acute kidney injuries raise the risk of dementia.

  • The researchers looked at the health data from thousands of older adults who had an acute kidney injury, which is when the kidneys suddenly stop functioning correctly.
  • They found that acute kidney injuries are associated with a substantially increased risk for dementia, particularly Lewy body dementia or Parkinson’s disease-related dementia. 

Dementia affects millions of people in the United States, and some experts believe that case numbers will continue to rise in the coming years.

Follow the link below for the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/acute-kidney-injury-linked-to-higher-risk-of-some-forms-of-dementia

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.
- Advertisement -